TIL Immunotherapy uses your own cells by reprogramming them to attack your cancer cells. Doctors surgically extract specific cells, called tumor-infiltrating lymphocytes, from your cancerous tumor and isolate them in a specialized laboratory. These cells are then genetically engineered to target and attack your cancer cells before they are injected back into your body.
TIL is on the cutting-edge of cancer treatments around the world. At present, it is only available by a few medical institutions as a progressive and highly effective therapy for melanoma. Sheba Medical Center is the only hospital to offer TIL to patients with recalcitrant ovarian cancer. Ovarian cancer is often resistant to treatment, and our advanced TIL treatment brings new hope.